BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1158483)

  • 1. Selectivity index as a therapeutic guide in nephrotic syndrome.
    Prasad R; Dayal RS; Mittal VP; Srivastava VK; Bedi GK; Bhatnagar AK
    Indian Pediatr; 1975 Mar; 12(3):211-5. PubMed ID: 1158483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclophosphamide therapy of nephrotic syndrome in childhood].
    Krepler P; Rosenkranz A; Obiditsch-Mayer I; Stockinger L; Schatz H; Fritzsche H
    Arch Kinderheilkd; 1970; 181(3):268-82. PubMed ID: 4922851
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined treatment with cyclophosphamide and prednisolone can induce remission of nephrotic syndrome in a patient with renal amyloidosis, associated with rheumatoid arthritis.
    Maezawa A; Hiromura K; Mitsuhashi H; Tsukada Y; Kanai H; Yano S; Naruse T
    Clin Nephrol; 1994 Jul; 42(1):30-2. PubMed ID: 7923963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nephrotic syndrome in adults with 'minimal change' glomerular lesions.
    Cameron JS; Turner DR; Ogg CS; Sharpstone P; Brown CB
    Q J Med; 1974 Jul; 43(171):461-88. PubMed ID: 4422336
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic nephrotic syndrome of childhood: cyclophosphamide induced conversion from steroid refractory to highly steroid sensitive disease.
    Bergstrand A; Bollgren I; Samuelsson A; Törnroth T; Wasserman J; Winberg J
    Clin Nephrol; 1973; 1(5):302-6. PubMed ID: 4129067
    [No Abstract]   [Full Text] [Related]  

  • 7. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
    Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
    Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
    Beaman M; Howie AJ; Hardwicke J; Michael J; Adu D
    Clin Nephrol; 1987 May; 27(5):217-21. PubMed ID: 3594937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclophosphamide in the treatment of glomerulonephritis.
    Ibels LS; Palmer AA; Mahony JF; Stewart JH
    Prog Biochem Pharmacol; 1974; 9():65-81. PubMed ID: 4438383
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructural changes in minimal lesion nephrotic syndrome before and during cyclophosphamide therapy.
    Rathi AK; Bajpai VK; Shipstome AC; Malik GK; Gupta V
    Indian Pediatr; 1979 Oct; 16(10):887-95. PubMed ID: 536000
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood.
    Barratt TM; Soothill JF
    Lancet; 1970 Sep; 2(7671):479-82. PubMed ID: 4194935
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome.
    McCrory WW; Shibuya M; Lu WH; Lewy JE
    J Pediatr; 1973 Apr; 82(4):614-8. PubMed ID: 4698338
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to treatment with short term corticosteroids in nephrotic syndrome in children.
    Vaishnava S; Sagreya K; Bhattacharjee I; Tayal M; Batra BK; Malik YD
    Indian Pediatr; 1972 Jul; 9(7):387-90. PubMed ID: 4650192
    [No Abstract]   [Full Text] [Related]  

  • 15. How to manage a child with steroid-responsive nephrotic syndrome when dose of prednisolone is reduced or when placed on high-dose alternate day steroids.
    Niaudet P
    Pediatr Nephrol; 1992 Nov; 6(6):522. PubMed ID: 1482637
    [No Abstract]   [Full Text] [Related]  

  • 16. Selectivity of proteinuria and steroid response in idiopathic nephrotic syndrome.
    Chuan PL; Kok LY
    J Singapore Paediatr Soc; 1979; 21(1-2):78-84. PubMed ID: 548639
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide therapy in idiopathic nephrotic syndrome--a new treatment.
    Dundon S; Carroll R; Dunleavy M; Raftery J
    J Ir Med Assoc; 1971 May; 64(411):243-6. PubMed ID: 5578246
    [No Abstract]   [Full Text] [Related]  

  • 18. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide.
    Dundon S; O'Callaghan U; Raftery J
    Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlations between the selectivity index, the histological picture and therapeutic response in the infantile nephrotic syndrome].
    Genova R; Tamborino G
    Minerva Pediatr; 1974 Dec; 26(38):1902-9. PubMed ID: 4217886
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
    Drummond KN; Hillman DA; Marchessault JH; Feldman W
    Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.